OpenAI’s Founder’s ‘Immortality’ Investments Revealed

The artificial intelligence industry has been on the agenda lately with artificial intelligence tools that you can directly “write” with those who convert texts into text. Among them, the most popular are OpenAI AI tools such as DALL-E and ChatGPT released by However, OpenAI will be much more in the near future. in different sectors also looks like it will show up.

Founder of OpenAI Sam AltmanIt turned out that he was also interested in “immortality”. The famous businessman invested 180 million dollars in a company called Retro Biosciences. Retro Biosciences, which appears as a biotechnology company, is the life expectancy of a healthy person. for a 10-year extension some work in progress.

Sam Altman cared about immortality studies in the past

In the statements made about the event brought up by the MIT Technology Review, Sam Altman actually years ago It is stated that he was interested in immortality and even carried out a study called “young blood” and turned this study into an article. As part of the young blood study, the skins of young mice were stitched to old mice, resulting in brain and muscle tissue from old mice. there is rejuvenation had been detected.

That’s not the only interesting thing about Sam Altman’s investment. business person for years Joe Betts – LaCroix Partnered with a scientist named So what does this name do today? Joe Betts-LaCroix is ​​the number one name in Retro Biosciences. Betts-LaCroix, during his statements on the subject, stated that Altman’s work was not limited to this, and that in 2020, blood plasma from old mice was obtained. of dilution He also stated that they have done research on whether it has a rejuvenating effect.